Personal tools
Document Actions

About BioPredictive

eprouvette.jpg

Biopredictive

Non-invasive liver diagnostic tests.
The goal of BioPredictive is the discovery and development of new non-invasive diagnostic tests which aim to improve the management of liver disease.
After FibroTest's launch in 2002, which has since turned out to be the reference in its field,  BioPredictive is once again breaking new ground with the SteatoTest, the NashTest, the AshTest and the FibroMax.


Partners

biotech.png assistance.png house.png

Scientific Comitee

The scientific committee is composed of:
- Pr Alfredo Alberti, Department of Internal Medicine, University of Padua, Italy.
- Pr Dominique Bellet, Institut Gustave Roussy, Department of Clinical Biology and CNRS ESA 18067 Immunology of Tumors, Pharmaceutic Faculty, Paris, France.
- Pr Patrice Cacoub, Department of Internal Medecine, Groupe Hospitalier Pitié Salpétrière, Paris, France.
- Pr Rafael Esteban, Hepatology Department, Hospital Valld'Hebron, Barcelona, Spain.
- Pr Michael Manns,Division of Gastroenterology and Hepatology, Medical School of Hannover, Germany.
- Pr Ching-Lung Lai,Department of Medicine, Queen Mary Hospital, Hong Kong SAR, China.
- Pr John McHutchison, MD, Duke Clinical Research Institute, Durham, NC 27715, USA.

univparis5.png univpetmcurie.png cnrs.png

Presse

Extrait Interview du Pr Thierry Poynard dans Paris-Match.

"L’équipe du Pr Thierry Poynard, chef du service d’hépato-gastro-entérologie à l’hôpital de la Pitié-Salpêtrière, a mis au point un nouveau test de diagnostic des maladies chroniques du foie. Il nous en explique les principes. [...]"


Vidéo

Journal Télévisé de TF1 du 21 Janvier 2006

BioPredictive et le FibroTest dans le journal phare de TF1.

 
Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: